69226-63-7

Basic information

• Product Name: (3-Methoxyphenethyl)urea
• Synonyms: (3-Methoxyphenethyl)urea;[2-(3-Methoxy-phenyl)-ethyl]-urea;1-(3-methoxyphenethyl)urea
• CAS NO: 69226-63-7
• Molecular Formula: C₁₀H₁₄N₂O₂
• Molecular Weight: 194.2304
• Mol File: 69226-63-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 342.5°Cat760mmHg
• Flash Point: 160.9°C
• Appearance: /
• Density: 1.126g/cm³
• Vapor Pressure: 7.51E-05mmHg at 25°C
• Refractive Index: 1.542
• CAS DataBase Reference: (3-Methoxyphenethyl)urea(CAS DataBase Reference)
• NIST Chemistry Reference: (3-Methoxyphenethyl)urea(69226-63-7)
• EPA Substance Registry System: (3-Methoxyphenethyl)urea(69226-63-7)

Safety Data

• Hazardous Substances Data: 69226-63-7(Hazardous Substances Data)

Usage

Description

(3-Methoxyphenethyl)urea, also known as MPEU, is a chemical compound with the molecular formula C9H12N2O2. It is a derivative of phenethylamine and urea, and is commonly used in the field of medicinal chemistry and pharmaceutical research.
Used in Pharmaceutical Research:
(3-Methoxyphenethyl)urea is used as a research compound for its potential therapeutic properties, including its ability to act as a dopamine D4 receptor antagonist, which may have implications for the treatment of conditions such as schizophrenia and bipolar disorder.
Used in Antioxidant and Anti-Inflammatory Research:
(3-Methoxyphenethyl)urea is used as a candidate for further research in the development of new drugs and treatments due to its potential antioxidant and anti-inflammatory effects.

InChI:InChI=1/C10H14N2O2/c1-14-9-4-2-3-8(7-9)5-6-12-10(11)13/h2-4,7H,5-6H2,1H3,(H3,11,12,13)

Upstream product

• 590-28-3 potassium cyanate 
• 2039-67-0 2-(3-methoxyphenyl)-1-ethanamine 
• 57-13-6 urea 

Downstream Products

• 1445847-84-6 [2-(3-hydroxy-phenyl)-ethyl]-urea 
• 1445847-85-7 [2-(3-allyloxy-phenyl)-ethyl]urea 
• 1445847-86-8 1-[2-(3-allyloxy-phenyl)-ethyl]-pyrimidine-2,4,6-trione 
• 1445847-95-9 9-(benzhydrylidene-amino)-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one 
• 1369253-00-8 5-(2-cyano-4-(((9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-yl)(methyl)amino)methyl)phenoxy)nicotinonitrile 
• 1369252-93-6 2-((3,5-difluoro-4-(3-(trifluoromethyl)phenoxy)benzyl)amino)-9-methoxy-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one 
• 1369252-92-5 9-methoxy-2-((4-(3-(trifluoromethyl)phenoxy)benzyl)oxy)-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one 
• 1369252-89-0 5-({[9-(methyloxy)-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-yl]oxy}methyl)-2-{[6-(trifluoromethyl)-3-pyridinyl]oxy}benzonitrile 
• 1369252-78-7 2-((4-((5-chloropyridin-3-yl)oxy)benzyl)amino)-9-methoxy-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one 
• 1369252-77-6 2-((5-chloropyridin-3-yl)oxy)-5-(((9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-yl)amino)methyl)benzonitrile 
• 1369252-36-7 2-{[(2-chloro-4-{[4-chloro-3-(trifluoromethyl)phenyl]oxy}phenyl)methyl]oxy}-9-(methyloxy)-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one 
• 1369252-34-5 5-((9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-yl)oxy)-2-(3-(trifluoromethyl)phenoxy)benzonitrile 
• 830358-48-0 1-[2-(3-methoxy-phenyl)-ethyl]-pyrimidine-2,4,6-trione 

Relevant articles and documents

NOVEL DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS.

A compound according to Formula Ia: wherein L1, G, and R1 are as described herein. The present invention relates to novel compounds according to Formula I that antagonize GPR84, a G-protein-coupled receptor that is involved in inflam